Newsroom

Hong Kong, China - Rotam Expands Its Commercial Development of Dicamba in USA

Rotam Expands Its Commercial Development of Dicamba in USA   

Hong Kong, China, 6 September 2013 – Rotam has announced today that it has acquired an EPA registration for dicamba technical and dicamba 480 SL as part of its global strategy to expand with this molecule in the US. Jean Michel Duhamel, Chief Commercial Officer explains: “The US market is a key focus for Rotam as it seeks to continue its rapid growth globally. Dicamba is the first of several molecules Rotam will bring to the US market within the next few years. It will be commercialized under the name of TopekaTM.”  

 

 

Rotam has the ambition to become one of the leading alternative sources of dicamba in the next decade which implies being present in key markets like USA as well as in the EU where the molecule is already registered and sold (France, UK and Italy). Besides, the company is implementing its Innovation Proprietary Post Patent strategy by evaluating new dicamba based mixtures in order to provide unique herbicide solution with stronger agronomic value to the maize growers. 

 

-Ends-

 

For more information contact Rotam at press@rotam.com. 

Notes to editor:

More about Rotam

Rotam delivers fully integrated research and development, global product registration, manufacturing, marketing and technical support to produce high quality crop protection products and service within the innovative proprietary post patent market. 


Selling branded, finished products in over 60 countries worldwide, the business is supported by a network of strategic partnerships, with national and regional distributors. 

www.rotam.com